Paper
12 January 1995 Carrier systems in PDT: on the way to novel antitumor drugs
Joerg G. Moser, Anja Ruebner-Heuermann, Peter Oehr, Hugo Scheer, Anja Vervoorts, Sonja Andrees
Author Affiliations +
Proceedings Volume 2325, Photodynamic Therapy of Cancer II; (1995) https://doi.org/10.1117/12.199131
Event: International Symposium on Biomedical Optics Europe '94, 1994, Lille, France
Abstract
A novel mode to apply photosensitizing drugs specifically to tumor tissue using the principles of polyphasic tumor therapies is outlined. Key compounds are tumor specific functionalized antibodies with reduced immunogenicity. These bind to drug inclusion complexes in a multiplicative manner. Drug inclusion complexes are designed on the basis of tethered functionalized (beta) -cyclodextrin dimers with maximum affinity to porphyrinoid photosensitizers forming monomeric chlathrates. To enhance porphyrin-cyclodextrin interaction peripheral groups of the porphyrin have to be chemically modified. The development of the method is not yet completed. First results are demonstrated.
© (1995) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Joerg G. Moser, Anja Ruebner-Heuermann, Peter Oehr, Hugo Scheer, Anja Vervoorts, and Sonja Andrees "Carrier systems in PDT: on the way to novel antitumor drugs", Proc. SPIE 2325, Photodynamic Therapy of Cancer II, (12 January 1995); https://doi.org/10.1117/12.199131
Lens.org Logo
CITATIONS
Cited by 5 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Photodynamic therapy

Cancer

Proteins

Tissue optics

Therapeutics

Laser therapeutics

Back to Top